0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 261-280 of 522 Articles
Invited Commentary | 
Ralph Gonzales, MD, MSPH; Sara Ackerman, PhD, MPH; Margaret Handley, PhD, MPH
Arch Intern Med. 2012;172(19):1471-1473. doi:10.1001/2013.jamainternmed.532.

Original Investigation |  FREE
Yuting Zhang, PhD; Michael A. Steinman, MD; Cameron M. Kaplan, PhD
Arch Intern Med. 2012;172(19):1465-1471. doi:10.1001/archinternmed.2012.3717.
Includes: Supplemental Content

Research Letters |  FREE
Tarayn Fairlie, MD, MPH; Daniel J. Shapiro, BA; Adam L. Hersh, MD, PhD; et al.
Arch Intern Med. 2012;172(19):1513-1514. doi:10.1001/archinternmed.2012.4089.

Special Article | 
Philip M. Rosoff, MD, MA; Kuldip R. Patel, PharmD; Ann Scates, PharmD; et al.
Arch Intern Med. 2012;172(19):1494-1499. doi:10.1001/archinternmed.2012.4367.
Includes: Supplemental Content

Editor's Correspondence | 
Joel W. Hay, PhD
Arch Intern Med. 2012;172(19):1521-1522. doi:10.1001/archinternmed.2012.4386.

Editor's Correspondence | 
Alain Braillon, MD, PhD
Arch Intern Med. 2012;172(19):1522-1523. doi:10.1001/archinternmed.2012.4389.

Editor's Correspondence | 
Nicholas S. Downing, AB; Joseph S. Ross, MD, MHS; Harlan M. Krumholz, MD, SM
Arch Intern Med. 2012;172(19):1522-1523. doi:10.1001/2013.jamainternmed.806.

Editor's Correspondence | 
Raffaele Marfella, MD, PhD; Carlo Carella, MD; Giuseppe Paolisso, MD, PhD
Arch Intern Med. 2012;172(19):1523-1524. doi:10.1001/archinternmed.2012.4409.

Editor's Correspondence | 
Salman Razvi, MD, FRCP; Simon H. S. Pearce, MD, FRCP
Arch Intern Med. 2012;172(19):1523-1524. doi:10.1001/2013.jamainternmed.597.

Invited Commentary | 
Chee M. Chan, MD, MPH; Andrew F. Shorr, MD, MPH
Arch Intern Med. 2012;172(18):1375-1376. doi:10.1001/archinternmed.2012.3650.

Invited Commentary | 
James S. Floyd, MD, MS; Bruce M. Psaty, MD, PhD
Arch Intern Med. 2012;172(18):1412-1414. doi:10.1001/archinternmed.2012.4306.

Editor's Correspondence | 
Kim L. Lavoie, PhD; Tavis S. Campbell, PhD; Simon L. Bacon, PhD
Arch Intern Med. 2012;172(17):1351-1352. doi:10.1001/archinternmed.2012.2575.

Editor's Correspondence | 
Daniel H. Solomon, MD, MPH; Maura Daly Iversen, PT, DPT, SD, MPH; Jeffrey N. Katz, MD, MSc
Arch Intern Med. 2012;172(17):1351-1352. doi:10.1001/archinternmed.2012.3409.

Editor's Correspondence | 
James M. Wright, MD, PhD, CRCP(C); Ken L. Bassett, MD, PhD; Aaron M. Tejani, BSc(Pharm), PharmD
Arch Intern Med. 2012;172(17):1352-1353. doi:10.1001/archinternmed.2012.3723.

Research Letters |  FREE
Raman Ravi Khanna, MD, MAS; Ronald G. Victor, MD; Kirsten Bibbins-Domingo, PhD, MD; et al.
Arch Intern Med. 2012;172(17):1344-1345. doi:10.1001/archinternmed.2012.2749.
Includes: Supplemental Content

Research Letters |  FREE
Abeer Ahmad, MSc; Giel Nijpels, MD, PhD; Jacqueline M. Dekker, PhD; et al.
Arch Intern Med. 2012;172(17):1346-1347. doi:10.1001/archinternmed.2012.2816.

Commentary | 
Jane C. Ballantyne, MD, FRCA; Mark D. Sullivan, MD, PhD; Andrew Kolodny, MD
Arch Intern Med. 2012;172(17):1342-1343. doi:10.1001/archinternmed.2012.3212.

Original Investigation |  FREE
Luigia Elzi, MD, MSc; Stefan Erb, MD; Hansjakob Furrer, MD; et al.
Arch Intern Med. 2012;172(17):1313-1321. doi:10.1001/archinternmed.2012.3216.

Invited Commentary | 
Daniel R. Kuritzkes, MD
Arch Intern Med. 2012;172(17):1321-1323. doi:10.1001/archinternmed.2012.3644.

Research Letters |  FREE
Christopher M. Jones, PharmD, MPH
Arch Intern Med. 2012;172(16):1265-1267. doi:10.1001/archinternmed.2012.2533.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Viewpoint  | 
Evaluation of Flibanserin Science and Advocacy at the FDA
Walid F. Gellad, MD, MPH; Kathryn E. Flynn, PhD; G. Caleb Alexander, MD, MS
JAMA Psychiatry
Original Investigation  | 
Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia A Prospective Dopamine D2/3 Receptor Occupancy Study
Ariel Graff-Guerrero, MD, PhD; Tarek K. Rajji, MD; Benoit H. Mulsant, MD, MS; et al.
JAMA Oncology
From The JAMA Network  | 
Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy
Jennifer A. Lo, BA; David E. Fisher, MD, PhD; Keith T. Flaherty, MD
JAMA Pediatrics
Viewpoint  | 
Global Collaboration to Develop New and Existing Drugs for Neonates
Jonathan M. Davis, MD; Mark A. Turner, MB, PhD, MRCPCH